Zysense

Zysense is a private analytical instrumentation company focused on nitric oxide and related gas measurement systems used in biomedical research, pharmaceutical research, and selected clinical research applications. Its flagship product, the NOA 280i nitric oxide analyzer, is positioned as a gold-standard instrument for measuring nitric oxide and related analytes in exhaled breath and biological liquid samples such as blood, plasma, serum, urine, and cell cultures. The company also offers multi-gas monitoring systems and support services for research and investigational clinical settings, including pulmonary hypertension and COVID-19-related monitoring use cases. Zysense traces its roots to Zysense Instruments, founded in 1984, and in June 2016 acquired the NOA 280i assets from General Electric. Overall, Zysense is best understood as a life science tools and specialty medical instrumentation company rather than a therapeutic drug developer.